Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.42+0.02 (+0.31%)
Close on Nov 13, 2026Market cap $243.02MP/E –Yield –
Lifecore Biomedical cash
Cash and short-term investments held at the end of each period.
Lifecore Biomedical's cash was $23.04M at Sep 30, 2026. For fiscal 2025 it was $8.27M, down 2.3% from the year before. Over ten years it grew -5.2% a year on average. The highest annual figure on record is $43.46M in fiscal 2009.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | May 25, 2025 | $8.27M | -2.3% |
| FY2024 | May 26, 2024 | $8.46M | -55.7% |
| FY2023 | May 28, 2023 | $19.09M | +1062.0% |
| FY2022 | May 29, 2022 | $1.64M | +26.9% |
| FY2021 | May 30, 2021 | $1.30M | +134.2% |
| FY2020 | May 31, 2020 | $553.00K | -62.3% |
| FY2019 | May 26, 2019 | $1.47M | -54.4% |
| FY2018 | May 27, 2018 | $3.22M | -43.9% |
| FY2017 | May 28, 2017 | $5.73M | -42.5% |
| FY2016 | May 29, 2016 | $9.97M | -29.4% |
| FY2015 | May 31, 2015 | $14.13M | -0.8% |
| FY2014 | May 25, 2014 | $14.24M | -6.7% |
| FY2013 | May 26, 2013 | $15.26M | -31.2% |
| FY2012 | May 27, 2012 | $22.18M | -38.8% |
| FY2011 | May 29, 2011 | $36.26M | +30.3% |
| FY2010 | May 30, 2010 | $27.82M | -36.0% |
| FY2009 | May 31, 2009 | $43.46M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2027CQ1 2026 | Sep 30, 2026 | $23.04M | +325.4% |
| Q2 FY2027CQ4 2025 | Jun 30, 2026 | $17.24M | +82.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $18.86M | +241.6% |
| Q4 FY2025CQ2 2025 | May 25, 2025 | $8.27M | -2.3% |
| Q3 FY2025CQ1 2025 | Feb 23, 2025 | $5.42M | +76.2% |
| Q2 FY2025CQ4 2024 | Nov 24, 2024 | $9.46M | +193.5% |
| Q1 FY2025CQ3 2024 | Aug 25, 2024 | $5.52M | -36.1% |
| Q4 FY2024CQ2 2024 | May 26, 2024 | $8.46M | -55.7% |
| Q3 FY2024CQ1 2024 | Feb 25, 2024 | $3.07M | +4.2% |
| Q2 FY2024CQ4 2023 | Nov 26, 2023 | $3.22M | -52.8% |
| Q1 FY2024CQ3 2023 | Aug 27, 2023 | $8.64M | +104.7% |
| Q4 FY2023CQ2 2023 | May 28, 2023 | $19.09M | +1062.0% |
| Q3 FY2023CQ1 2023 | Feb 26, 2023 | $2.95M | +167.9% |
| Q2 FY2023CQ4 2022 | Nov 27, 2022 | $6.83M | +1021.5% |
| Q1 FY2023CQ3 2022 | Aug 28, 2022 | $4.22M | +349.6% |
| Q4 FY2022CQ2 2022 | May 29, 2022 | $1.64M | +26.9% |
| Q3 FY2022CQ1 2022 | Feb 27, 2022 | $1.10M | -40.6% |
| Q2 FY2022CQ4 2021 | Nov 28, 2021 | $609.00K | -75.4% |
| Q1 FY2022CQ3 2021 | Aug 29, 2021 | $939.00K | +113.9% |
| Q4 FY2021CQ2 2021 | May 30, 2021 | $1.30M | +134.2% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $1.85M | -28.9% |
| Q2 FY2021CQ4 2020 | Nov 29, 2020 | $2.48M | +55.3% |
| Q1 FY2021CQ3 2020 | Aug 30, 2020 | $439.00K | -77.9% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $553.00K | -62.3% |
| Q3 FY2020CQ1 2020 | Feb 23, 2020 | $2.61M | +51.4% |
| Q2 FY2020CQ4 2019 | Nov 24, 2019 | $1.59M | +5.3% |
| Q1 FY2020CQ3 2019 | Aug 25, 2019 | $1.99M | +46.4% |
| Q4 FY2019CQ2 2019 | May 26, 2019 | $1.47M | -54.4% |
| Q3 FY2019CQ1 2019 | Feb 24, 2019 | $1.72M | -77.5% |
| Q2 FY2019CQ4 2018 | Nov 25, 2018 | $1.51M | -67.1% |
| Q1 FY2019CQ3 2018 | Aug 26, 2018 | $1.36M | -83.6% |
| Q4 FY2018CQ2 2018 | May 27, 2018 | $3.22M | -43.9% |
| Q3 FY2018CQ1 2018 | Feb 25, 2018 | $7.66M | -39.8% |
| Q2 FY2018CQ4 2017 | Nov 26, 2017 | $4.60M | +79.3% |
| Q1 FY2018CQ3 2017 | Aug 27, 2017 | $8.26M | -4.2% |
| Q4 FY2017CQ2 2017 | May 28, 2017 | $5.73M | -42.5% |
| Q3 FY2017CQ1 2017 | Feb 26, 2017 | $12.73M | – |
| Q2 FY2017CQ4 2016 | Nov 27, 2016 | $2.57M | – |
| Q1 FY2017CQ3 2016 | Aug 28, 2016 | $8.63M | – |
| Q4 FY2016CQ2 2016 | May 29, 2016 | $9.97M | – |
See a number that looks wrong?